Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - albendazole - tablets - albendazole 400 mg - albendazole - albendazole - albendazole is indicated for the treatment of the following systemic helminth diseases: * echinococcosis (hydatid disease)albendazole is indicated for the treatment of liver, lung and peritoneal cysts. experience with bone cysts and those in the central nervous system and heart is limited. * cystic echinococcosis (caused by echinococcus granulosus)albendazole is used in patients with cystic echinococcosis:1. when surgical intervention is not feasible .2. as a co-adjunct to surgical treatment. 3. prior to surgical intervention. 4. if preoperative treatment was too short, if spillage has occurred or if viable cysts were found at surgery. 5. following percutaneous drainage of cysts for diagnostic or therapeutic reasons. * alveolar echinococcosis (caused by echinococcus multilocularis)although its efficacy has not been completely demonstrated in clinical trials, albendazole is used in patients with alveolar echinococcosis in the following situations:1. in inoperable disease, particularly in cases of local or distant metastasis.2. following palliative surgery.3. following radical surgery or liver transplantation.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - oxymetazoline hydrochloride - nasal spray, solution - oxymetazoline hydrochloride 0.05 %w/v - oxymetazoline - oxymetazoline - relief of nasal congestion, which is a result of common colds, sinusitis, hay fever or allergies of the upper respiratory system.

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - oxymetazoline hydrochloride - solution - oxymetazoline hydrochloride 0.05 % - oxymetazoline - oxymetazoline - relief of nasal congestion, which is a result of common colds, sinusitis, hay fever or allergies of the upper respiratory system.

Israel - English - Ministry of Health

novartis israel ltd - nepafenac - ophthalmic suspension - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Israel - English - Ministry of Health

rafa laboratories ltd - dorzolamide as hydrochloride - ophthalmic solution - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.

Israel - English - Ministry of Health

rafa laboratories ltd - timolol as maleate - eye drops, solution - timolol as maleate 5 mg/ml - timolol - timolol - for the reduction of elevated intraocular pressure may be used in patients with chronic open-angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension

Israel - English - Ministry of Health

novartis israel ltd - ranibizumab - solution for injection - ranibizumab 10 mg/ml - ranibizumab - ranibizumab - treatment of patients with neovascular (wet) age-related macular degeneration (amd). treatment of adult patients with visual impairment due to diabetic macular oedema (dme) . the treatment of visual impairement due to macular oedema secondary to retinal vein occlusion (rvo). the treatment of visual impaiment due to choroidal neovascularization (cnv) . lucentis is indicated in preterm infants for: the treatment of retinopathy of prematurity (rop) with zone i (stage 1+, 2+, 3 or 3+), zone ii (stage 3+) or ap-rop (aggressive posterior rop) disease.the treatment of proliferative diabetic retinopathy (pdr)

Israel - English - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - powder for suspension - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ≥ 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Israel - English - Ministry of Health

promedico ltd - patent blue v sodium - solution for injection - patent blue v sodium 25 mg/ml - other diagnostic agents - marking lymph vessels and arterial regions.marking sentinel nodes before biopsy in patients with operable breast cancer.

Israel - English - Ministry of Health

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.5 mcg - vitamin d and analogues - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease)- primary and tertiary. - rickets and osteomalacia. - osteoporosis.